Global Medical REIT (GMRE) Misses Q2 EPS by 2c ; Provides Outlook

Global Medical REIT (NYSE: GMRE) reported Q2 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $37.9 million versus the consensus estimate of $35.39 million.

2025 Guidance

The Company is reaffirming its full year 2025 AFFO per share and unit guidance of $0.89 to $0.93.

For earnings history and earnings-related data on Global Medical REIT (GMRE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT